Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 15 matching records.
15 results — page 1 of 1
- Level DAnimal StudyEurope PMC
Intravenous Human Umbilical Cord-Derived Mesenchymal Stromal Cells Promote Functional Recovery after Experimental Intracerebral Hemorrhage Via Local and Systemic Immunomodulation
Animal Study on Chronic Inflammation, Immune Modulation, published in Transl Stroke Res (2026) — summary generated from the PubMed abstract.
- 2026
Transl Stroke Res - Level BClinical TrialEurope PMC
Allogeneic umbilical cord-derived mesenchymal stromal cells for treatment of refractory lupus nephritis: a real-world study
Clinical Trial on Chronic Kidney Disease, Autoimmune Research, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Res Ther - Level DLaboratory StudyPubMed
Superior migration ability of umbilical cord-derived mesenchymal stromal cells (MSCs) toward activated lymphocytes in comparison with those of bone marrow and adipose-derived MSCs.
Laboratory Study, published in Front Cell Dev Biol (2024) — summary generated from the PubMed abstract.
- 2024
Front Cell Dev Biol - Level DAnimal StudyEurope PMC
Human umbilical cord-derived mesenchymal stromal cells improve myocardial fibrosis and restore miRNA-133a expression in diabetic cardiomyopathy
Animal Study on Cardiovascular Disease, published in Stem Cell Res Ther (2024) — summary generated from the PubMed abstract.
- 2024
Stem Cell Res Ther14 citations - Level BClinical TrialEurope PMC
Human umbilical cord-derived mesenchymal stromal cells for the treatment of steroid refractory grades III-IV acute graft-versus-host disease with long-term follow-up
Clinical Trial with a reported sample of 86 on Immune Modulation, published in Front Immunol (2024) — summary generated from the PubMed abstract.
- 2024
- n = 86
Front Immunol5 citations - Level CProspective StudyEurope PMC
Umbilical-Cord-Derived Mesenchymal Stromal Cells Modulate 26 Out of 41 T Cell Subsets from Systemic Sclerosis Patients
Prospective Study with a reported sample of 6 on Immune Modulation, published in Biomedicines (2023) — summary generated from the PubMed abstract.
- 2023
- n = 6
Biomedicines6 citations - Level DLaboratory StudyEurope PMC
Comparative Bioactivity Analysis for Off-the-Shelf and Culture-Rescued Umbilical Cord-Derived Mesenchymal Stem/Stromal Cells in a Xeno- and Serum-Free Culture System
Laboratory Study on Immune Modulation, published in Cell Transplant (2021) — summary generated from the PubMed abstract.
- 2021
Cell Transplant6 citations - Level DAnimal StudyEurope PMC
Human Platelet Lysate Maintains Stemness of Umbilical Cord-Derived Mesenchymal Stromal Cells and Promote Lung Repair in Rat Bronchopulmonary Dysplasia
Animal Study, published in Front Cell Dev Biol (2021) — summary generated from the PubMed abstract.
- 2021
Front Cell Dev Biol7 citations - Level DAnimal StudyPubMed
A Protocol for the Isolation, Culture, and Cryopreservation of Umbilical Cord-Derived Canine Mesenchymal Stromal Cells: Role of Cell Attachment in Long-Term Maintenance.
Animal Study on Osteoarthritis, Chronic Inflammation, Autoimmune Research, published in Stem Cells Dev (2020) — summary generated from the PubMed abstract.
- 2020
Stem Cells Dev - Level DLaboratory StudyEurope PMC
Effect of Conditioned Medium from Human Umbilical Cord-Derived Mesenchymal Stromal Cells on Rejuvenation of Nucleus Pulposus Derived Stem/Progenitor Cells from Degenerated Intervertebral Disc
Laboratory Study on Disc Degeneration, published in Int J Stem Cells (2020) — summary generated from the PubMed abstract.
- 2020
Int J Stem Cells15 citations - Level BRandomized Controlled TrialPubMed
Umbilical Cord-Derived Mesenchymal Stromal Cells (MSCs) for Knee Osteoarthritis: Repeated MSC Dosing Is Superior to a Single MSC Dose and to Hyaluronic Acid in a Controlled Randomized Phase I/II Trial.
Randomized Controlled Trial with a reported sample of 8 on Knee Osteoarthritis, Osteoarthritis, published in Stem Cells Transl Med (2018) — summary generated from the PubMed abstract.
- 2018
- n = 8
Stem Cells Transl Med - Level DAnimal StudyPubMed
Human umbilical cord-derived mesenchymal stromal cells protect against premature renal senescence resulting from oxidative stress in rats with acute kidney injury.
Animal Study on Acute Kidney Injury, published in Stem Cell Res Ther (2017) — summary generated from the PubMed abstract.
- 2017
Stem Cell Res Ther - Level DAnimal StudyPubMed
Intravenous injection of umbilical cord-derived mesenchymal stromal cells attenuates reactive gliosis and hypomyelination in a neonatal intraventricular hemorrhage model.
Animal Study on Back & Spine, Systemic / IV, published in Neuroscience (2017) — summary generated from the PubMed abstract.
- 2017
Neuroscience - Level DLaboratory StudyEurope PMC
Urothelial differentiation of human umbilical cord-derived mesenchymal stromal cells in vitro
Laboratory Study, published in Anal Cell Pathol (Amst) (2013) — summary generated from the PubMed abstract.
- 2013
Anal Cell Pathol (Amst)16 citations - Level CProspective StudyPubMed
Osteogenic potential of human umbilical cord-derived mesenchymal stromal cells cultured with umbilical cord blood-derived autoserum.
Prospective Study, published in J Craniomaxillofac Surg (2012) — summary generated from the PubMed abstract.
- 2012
J Craniomaxillofac Surg
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406